RBC Europe’s Galectin Therapeutics GALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-40
| Closed | -$155 | – | 815 |
|
|
2021
Q3 | $155 | Hold |
40
| – | – | ﹤0.01% | 1216 |
|
|
2021
Q2 | $128 | Hold |
40
| – | – | ﹤0.01% | 1210 |
|
|
2021
Q1 | $87 | Hold |
40
| – | – | ﹤0.01% | 1164 |
|
|
2020
Q4 | $90 | Hold |
40
| – | – | ﹤0.01% | 1134 |
|
|
2020
Q3 | $107 | Hold |
40
| – | – | ﹤0.01% | 1079 |
|
|
2020
Q2 | $122 | Hold |
40
| – | – | ﹤0.01% | 1040 |
|
|
2020
Q1 | $78 | Hold |
40
| – | – | ﹤0.01% | 1023 |
|
|
2019
Q4 | $114 | Hold |
40
| – | – | ﹤0.01% | 1031 |
|
|
2019
Q3 | $147 | Hold |
40
| – | – | ﹤0.01% | 1028 |
|
|
2019
Q2 | $166 | Hold |
40
| – | – | ﹤0.01% | 1043 |
|
|
2019
Q1 | $204 | Hold |
40
| – | – | ﹤0.01% | 1054 |
|
|
2018
Q4 | $137 | Hold |
40
| – | – | ﹤0.01% | 1067 |
|
|
2018
Q3 | $240 | Hold |
40
| – | – | ﹤0.01% | 1103 |
|
|
2018
Q2 | $254 | Hold |
40
| – | – | ﹤0.01% | 1114 |
|
|
2018
Q1 | $190 | Hold |
40
| – | – | ﹤0.01% | 1095 |
|
|
2017
Q4 | $134 | Hold |
40
| – | – | ﹤0.01% | 1115 |
|
|
2017
Q3 | $86 | Buy |
+40
| New | +$86 | ﹤0.01% | 1122 |
|